| RECCE PHARMACEUTICALS LTD |
| Australien |
| Gesundheit |
| AU000000RCE5 / A2ADQM |
| R9Q (Frankfurt) |
| FRA:R9Q, ETR:R9Q, R9Q:GR |
| - |
| https://www.recce.com.au/ |
|
Recce Pharmaceuticals Ltd is a publicly listed biotechnology company specializing in the development of a pioneering class of synthetic anti-infective therapies. Its primary mission is to address the escalating global health threat posed by antibioti..
>Volltext.. |
| 52.72 Mio. EUR |
| 57.4 Mio. EUR |
| - |
| -13.76 Mio. EUR |
| -9.21 Mio. EUR |
| -0.03 EUR |
| 6.43 Mio. EUR |
| 1.66 Mio. EUR |
| -6.09 Mio. EUR |
| 0.17 |
| - |
| 24.24% |
| - |
| - |
| - |
| - |
| RECCE PHARMA, RECCE PHARMACEUTICALS, RECCE PHARMACEUTICAL |
| 20.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|